-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Ocular Therapeutix (OCUL)
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) PT Raised to $29 at Raymond James
-
-
-
-
-
-
-
Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) PT Raised to $7 at Raymond James As Phase 1 Data Impresses
-
-
-
-
-
-
-
Pre-Open Movers 8/22: (EXAS) (NEWA) (LZB) Higher; (SMCI) (NBEV) (GSM) Lower (more...)
-
-
-
-
-
32,346 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

